Last reviewed · How we verify

NCT03850457

Epidemiological Study for Bronchopulmonary Dysplasia (BPD) in China

Completed Last updated 25 February 2025
What this trial tests

trial testing No intervention in Bronchopulmonary Dysplasia in 3,800 participants. Completed in 31 March 2024.

Timeline
1 January 2020
Primary endpoint
30 November 2023
31 March 2024

Quick facts

Lead sponsorChildren's Hospital of Fudan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment3,800
Start date1 January 2020
Primary completion30 November 2023
Estimated completion31 March 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Fudan University

Who can join

Under 28 Days, any sex, with Bronchopulmonary Dysplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will establish a nationwide cohort of very preterm infants in China, to investigate the epidemiological characteristics and short-term outcomes of BPD in different NICUs around the country.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Diagnostic efficacy of targeted high-throughput sequencing for lower respiratory infection in preterm infants.
    Dai Y, Sheng K, Hu L. · · 2022 · cited 16× · PMID 36505277
  2. Multicentre online registration of bronchopulmonary dysplasia in very preterm infants in China: protocol for a prospective, open, observational cohort study.
    He S, Peng H, Zhou P, Hu F, et al · · 2024 · cited 1× · PMID 39581740 · DOI 10.1136/bmjopen-2024-085560

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Bronchopulmonary Dysplasia

Currently open trials in the same condition.

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03850457.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing